1985•PubMedRequires access

Captopril in the treatment of hypertension in type I and type II diabetic patients.

Giovanni Gambaro, Francesco Filippo Morbiato, Elisa Cicerello, Del Turco M, L Sartori, Angela D’Angelo, Gaetano Crepaldi

Open publisher page 17 citations

Abstract

Ten type I and 10 type II hypertensive diabetic patients were treated for 12 weeks with captopril (50 mg twice daily). Good control of blood pressure was achieved without any significant adverse effect on carbohydrate metabolism or renal haemodynamics and without evidence of glomerular or tubular damage.

About this research paper

What this paper is about

Ten type I and 10 type II hypertensive diabetic patients were treated for 12 weeks with captopril (50 mg twice daily). Good control of blood pressure was achieved without any significant adverse effect on carbohydrate metabolism or renal haemodynamics and without evidence of glomerular or tubular damage.

Why it matters

OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Ten type I and 10 type II hypertensive diabetic patients were treated for 12 weeks with captopril (50 mg twice daily). Good control of blood pressure was achieved without any significant adverse effect on carbohydrate metabolism or renal haemodynamics and without evidence of glomerular or tubular damage.

Key concepts: Medicine, Captopril, Blood pressure, Internal medicine, Hemodynamics, Adverse effect, Endocrinology, Cardiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Captopril in the treatment of hypertension in type I and type II diabetic patients. — Research Paper | ScholarLens